Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated:  12/2/2015
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated: 12/2/2015
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated:  12/2/2015
Wasatch Endocrinology And Diabetes Specialists
mi
from
Salt Lake City, UT
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated: 12/2/2015
Wasatch Endocrinology And Diabetes Specialists
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated:  12/2/2015
Millennium Clinical Trials, L.L.C.
mi
from
Arlington, VA
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated: 12/2/2015
Millennium Clinical Trials, L.L.C.
mi
from
Arlington, VA
Click here to add this to my saved trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated:  12/2/2015
Local Institution
mi
from
Camperdown,
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
Status: Enrolling
Updated: 12/2/2015
Local Institution
mi
from
Camperdown,
Click here to add this to my saved trials
Anastrozole in Patients With Pulmonary Arterial Hypertension
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/3/2015
University of Pennsylvania - Penn Presbyterian
mi
from
Philadelphia, PA
Anastrozole in Patients With Pulmonary Arterial Hypertension
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/3/2015
University of Pennsylvania - Penn Presbyterian
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Anastrozole in Patients With Pulmonary Arterial Hypertension
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/3/2015
University of Pennsylvania - Perelman Center
mi
from
Philadelphia, PA
Anastrozole in Patients With Pulmonary Arterial Hypertension
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/3/2015
University of Pennsylvania - Perelman Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Anastrozole in Patients With Pulmonary Arterial Hypertension
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/3/2015
Brown University - Rhode Island Hospital
mi
from
Providence, RI
Anastrozole in Patients With Pulmonary Arterial Hypertension
A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/3/2015
Brown University - Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Improving Heart Health in Appalachia
Reducing Health Disparities in Appalachians With Multiple Cardiovascular Disease Risk Factors
Status: Enrolling
Updated:  12/3/2015
University of Kentucky
mi
from
Lexington, KY
Improving Heart Health in Appalachia
Reducing Health Disparities in Appalachians With Multiple Cardiovascular Disease Risk Factors
Status: Enrolling
Updated: 12/3/2015
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
Status: Enrolling
Updated:  12/4/2015
Clinical Translational Research Center
mi
from
Boulder, CO
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older Adults
Status: Enrolling
Updated: 12/4/2015
Clinical Translational Research Center
mi
from
Boulder, CO
Click here to add this to my saved trials
Take Charge of Your Diabetes
Testing Enrollment Methods on Participation in Behavioral Economic Interventions for Diabetes Care: A Randomized Controlled Pilot Study
Status: Enrolling
Updated:  12/7/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Take Charge of Your Diabetes
Testing Enrollment Methods on Participation in Behavioral Economic Interventions for Diabetes Care: A Randomized Controlled Pilot Study
Status: Enrolling
Updated: 12/7/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
Children's Hospital Oakland
mi
from
Oakland, CA
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
University of Colorado
mi
from
Denver, CO
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
Howard University Hospital
mi
from
Washington,
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
Howard University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
Johns Hopkins University
mi
from
Baltimore, MD
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated:  12/7/2015
Imperial College London and Hammersmith Hospital
mi
from
London,
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Treatment of Pulmonary Hypertension and Sickle Cell Disease With Sildenafil Therapy
Status: Enrolling
Updated: 12/7/2015
Imperial College London and Hammersmith Hospital
mi
from
London,
Click here to add this to my saved trials
Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients
Adjunct Vitamin D Therapy as a Means to Reduce the Disparity in Subclinical Target Organ Cardiac Damage Among Vulnerable Hypertensive Patients
Status: Enrolling
Updated:  12/8/2015
Detroit Receiving Hospital
mi
from
Detroit, MI
Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients
Adjunct Vitamin D Therapy as a Means to Reduce the Disparity in Subclinical Target Organ Cardiac Damage Among Vulnerable Hypertensive Patients
Status: Enrolling
Updated: 12/8/2015
Detroit Receiving Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
The Medication Metronome Project
Status: Enrolling
Updated:  12/8/2015
Massachusetts General Hospital
mi
from
Boston, MA
The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and Care
The Medication Metronome Project
Status: Enrolling
Updated: 12/8/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/9/2015
Clinical Research Facility
mi
from
Racine, WI
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/9/2015
Clinical Research Facility
mi
from
Racine, WI
Click here to add this to my saved trials
Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial
Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial
Status: Enrolling
Updated:  12/11/2015
University of Michigan
mi
from
Ann Arbor, MI
Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial
Assessing Alternative Approaches for Blood Pressure Control: A3BC Trial
Status: Enrolling
Updated: 12/11/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hypertension in Hemodialysis Patients (Aim 3)
Hypertension in Hemodialysis Patients
Status: Enrolling
Updated:  12/14/2015
Indiana University
mi
from
Indianapolis, IN
Hypertension in Hemodialysis Patients (Aim 3)
Hypertension in Hemodialysis Patients
Status: Enrolling
Updated: 12/14/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure
Stress, Blood Pressure, & Ethnicity
Status: Enrolling
Updated:  12/16/2015
University of California, San Diego
mi
from
San Diego, CA
Evaluating the Relationship Between Stress, Ethnicity, and Blood Pressure
Stress, Blood Pressure, & Ethnicity
Status: Enrolling
Updated: 12/16/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Standardized Eucommia Extract in the Treatment of Hypertension
Evaluation of the Safety and Efficacy of a Standardized Eucommia Extract in the Treatment of Hypertension
Status: Enrolling
Updated:  12/17/2015
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Standardized Eucommia Extract in the Treatment of Hypertension
Evaluation of the Safety and Efficacy of a Standardized Eucommia Extract in the Treatment of Hypertension
Status: Enrolling
Updated: 12/17/2015
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Physicians Care Center
mi
from
Baton Rouge, LA
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Physicians Care Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Bradley L. Meek, MD, Internal Medicine at Hennessy
mi
from
Baton Rouge, LA
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Bradley L. Meek, MD, Internal Medicine at Hennessy
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Metabolic Clinic Women's Hospital
mi
from
Baton Rouge, LA
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Metabolic Clinic Women's Hospital
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Egan Wellness Clinic/AntiAging & Skin Care Spa
mi
from
Covington, LA
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Egan Wellness Clinic/AntiAging & Skin Care Spa
mi
from
Covington, LA
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Amarica Family Practice Office (Second Location)
mi
from
Durham, NC
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Amarica Family Practice Office (Second Location)
mi
from
Durham, NC
Click here to add this to my saved trials
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated:  12/17/2015
Amarica Family Practice Office (First Location)
mi
from
Roxboro, NC
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Prediabetes, Prehypertension and Vitamin D Supplementation - A Practice Based Clinical Intervention Pilot Study
Status: Enrolling
Updated: 12/17/2015
Amarica Family Practice Office (First Location)
mi
from
Roxboro, NC
Click here to add this to my saved trials
Interactive Web Program and Health Coaching for Prehypertensive Adults
Interactive Web Program and Health Coaching for Prehypertensive Adults
Status: Enrolling
Updated:  12/17/2015
ORCAS
mi
from
Eugene, OR
Interactive Web Program and Health Coaching for Prehypertensive Adults
Interactive Web Program and Health Coaching for Prehypertensive Adults
Status: Enrolling
Updated: 12/17/2015
ORCAS
mi
from
Eugene, OR
Click here to add this to my saved trials
Achieving Blood Pressure Control Through Enhanced Discharge
Achieving Blood Pressure Control Through Enhanced Discharge
Status: Enrolling
Updated:  12/18/2015
Detroit Receiving Hospital Emergency Department
mi
from
Detroit, MI
Achieving Blood Pressure Control Through Enhanced Discharge
Achieving Blood Pressure Control Through Enhanced Discharge
Status: Enrolling
Updated: 12/18/2015
Detroit Receiving Hospital Emergency Department
mi
from
Detroit, MI
Click here to add this to my saved trials
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise Testing
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise Testing
Status: Enrolling
Updated:  12/21/2015
University of Chicago
mi
from
Chicago, IL
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise Testing
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Exercise Testing
Status: Enrolling
Updated: 12/21/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
The Effect of Synching Prescription Refills on Adherence
A Randomized Controlled Trial to Test a Synchronized Prescription Refill Program to Improve Medication Adherence
Status: Enrolling
Updated:  12/21/2015
Humana, Inc
mi
from
Louisville, KY
The Effect of Synching Prescription Refills on Adherence
A Randomized Controlled Trial to Test a Synchronized Prescription Refill Program to Improve Medication Adherence
Status: Enrolling
Updated: 12/21/2015
Humana, Inc
mi
from
Louisville, KY
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigator Site
mi
from
Clearwater, FL
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigator Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigator Site
mi
from
Chicago, IL
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Metairie, LA
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Metairie, LA
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Belzoni, MS
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Belzoni, MS
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Jackson, MS
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Jackson, MS
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
St. Louis, MO
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Henderson, NV
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Henderson, NV
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Las Vegas, NV
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Buffalo, NY
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Charlotte, NC
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Greensboro, NC
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Shelby, NC
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Shelby, NC
Click here to add this to my saved trials
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated:  12/22/2015
Novartis Investigative Site
mi
from
Erie, PA
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension
A Multi-center, Randomized, Double-blind, Placebo and Active Controlled, Parallel Group Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg After 8 Week Treatment in Patients With Mild-to-moderate Systolic Hypertension
Status: Enrolling
Updated: 12/22/2015
Novartis Investigative Site
mi
from
Erie, PA
Click here to add this to my saved trials